Intellectual Property India Publishes Patent Application for 'Inhibitors Of Ptp1b / Nck1 Interaction And Methods Of Making And Using Same' Filed by Radella Pharmaceuticals Llc

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517089635 A) filed by Radella Pharmaceuticals Llc, Wilmington, U.S.A., on Sept. 19, for 'inhibitors of ptp1b / nck1 interaction and methods of making and using same.'

Inventor(s) include Delibegovic, Mirela; Dall'Angelo, Sergio; Hamer, Meghan Marie; Dekeryte, Ruta; Mcewan, Andrew Robert; and Greig, Iain Robert.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "The invention relates generally to synthetic peptides which bind NCK1. The invention further relates to methods of using the peptides for inhibiting an interaction between NCK1 and PTP1B,...